CORPORATE VISION

Build an ethical nutritional / wellness product company, specializing in disease-specific add-on products, that will gain a reputation for quality, value and therapeutic effectiveness within the Medical Community.

SCOPE

Genesis Center, Inc., established in September 1997. The company has developed a unique nutritional product line based on sound medical nutrition; health-care provider directed and designed to meet the unique metabolic and disease-specific needs of the individual.

Genesis is the first Product Company to focus on providing products to healthcare providers to enable them to recommend medically sound nutritional products to their clients.

PRODUCTS

Genesis's products are pharmaceutical grade and are formulated in therapeutic or pharmacological effective amounts.

The following are current products that have been private labeled:

• High Potency Vitamins and Antioxidants
• High Potency Minerals
• High Potency Trace Elements
• Soluble Fiber packets
• Cardiovascular - Hcy -- 1st "disease-specific" add on product for prevention of strokes and heart attacks and for the treatment of hyperhomocysteinemia.

PACKAGING

 

Each product will initially be available in bottles providing a months supply.

Future product packaging will include a day's supply of nutritional supplements in one packet to maximize convenience.

FUTURE PRODUCTS

The following are disease-specific or specific add-on products, which when administered along with the base product can provide medically sound nutritional therapy:

 

• Prostate -P (prevention of prostate cancer)
• Prostate-Sx (symptomatic treatment of BHP)
• Angina/CHF/HT/arrhythmia
• Dyslipidemias
• Anti-aging
• Anti-cancer Immune stimulants
• Ophthalmic -- Macular degeneration/cataracts
• Arthritis
• Osteoporosis -- men and women
• Life-style -- alcohol, smoking, weight loss
• Diabetes/Hypoglycemia
• Depression
• Alzheimers
• Fatique
• Impotency
• Respiratory -- asthma/bronchitis
• Ulcerative Colitis

THE SERVICE

Genesis will provide information to healthcare providers on product selection, patient assessment and clinical monitoring.

Inservices will be provided for support personnel on recommending and/or sale of the Genesis product line.

Lectures on nutrition, wellness, preventive medicine etc. will be provided to the public.

Newsletters and this website will be available for healthcare providers and users of the Genesis products.

The unique information that will be provided relates to therapeutic dosing, drug/food/laboratory interactions, outcome monitoring, disease specific scientific literature documentation, diet evaluations, pharmacological, and evaluation of drug induced nutritional deficiencies.

CLIENT BENEFITS

To the client, the benefit is a rational, effective, pharmaceutical grade, comprehensive product at an excellent value. Some direct marketing nutrition companies are unable to sell products at a value price because of the need to pay commissions to the down line. Many other products have ingredients in minuscule amounts that are listed only for label content to imply value to consumers not familiar with dosage requirements.

The client receives a comprehensive product in a minimal number of bottles and tablets that meet their cellular nutritional needs in appropriate dosages and in a rational balance.

When the consumer needs a "disease-specific" add on product, it is complementary to the base formulation so that clinical effectiveness can be monitored.

The physician or healthcare provider now has a comprehensive formula that is easy to understand, is supported by main stream medical literature that can reduce age-related medical problems that are preventable. The disease specific add-on products will be promoted by specialty e.g. prostate formulas to urologist, etc.; so their use is easily understood and monitored. Until the advent of Genesis, the physician has not had a resource of information or rational therapeutic products that could be recommended to patients with confidence.

TRAINING

Training in the area of clinical nutrition and therapeutics is the key to the perpetuation of product usage. Clinical management guidelines will be required to expand product usage with physicians.